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ccumulating evidence attests to
a prosurvival role for autophagy
under stress, by facilitating removal of
damaged proteins and organelles and
recycling basic building blocks, which
can be utilized for energy generation
and targeted macromolecular synthesis to shore up cellular defenses. These
observations are difficult to reconcile
with the dichotomous prosurvival and
death-inducing roles ascribed to macroautophagy in cardiac ischemia and
reperfusion injury, respectively. A careful reexamination of ‘flux’ through the
macroautophagy pathway reveals that
autophagosome clearance is markedly
impaired with reperfusion (reoxygenation) in cardiomyocytes following an
ischemic (hypoxic) insult, resulting from
reactive oxygen species (ROS)-mediated
decline in LAMP2 and increase in
BECN1 abundance. This results in
impaired autophagy that is ‘ineffective’
in protecting against cell death with
ischemia-reperfusion injury. Restoration
of autophagosome clearance and by
inference, ‘adequate’ autophagy, attenuates reoxygenation-induced cell death.
Myocardial infarction most commonly
results from thrombotic occlusion of a
coronary artery resulting in ischemia;
and spontaneous or therapeutic reperfusion offers the best hope for myocardial
salvage. However, reperfusion is accompanied by a burst of ROS generation and further injury, causing cardiomyocyte death
and myocardial dysfunction. Despite
significant research efforts, therapeutic
options for reperfusion injury are limited
to preventive pre-administration of pharmacological agents, which is impractical
in the clinical setting. Understanding the
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role of autophagy in cardiomyocyte death
in myocardial infarction, therefore, holds
tremendous promise in development of
strategies to promote myocardial salvage.
Contemporaneous studies have employed
autophagosome abundance as a readout
for autophagy, and conclude that induction of autophagy via activation of adenosine monophosphate-activated kinase
(AMPK) is beneficial during the ischemic
phase, but further activation of autophagy,
i.e. an increase in autophagosome prevalence, by BECN1 upregulation causes cell
death during reperfusion, thus presenting a conundrum in the development of a
therapeutic approach targeting autophagy
in ischemia-reperfusion injury.
Since ‘autophagy’ is a process, and
assessment of its efficiency should ideally
require assessment of the rate of degradation of its substrates (such as damaged
proteins and organelles) and/or the rate
of generation of the end products (amino
acids, sugars and lipids recycled back into
the cytosol from the lysosomes), reliance
on the levels of a single intermediate, such
as autophagosomes, may not yield accurate
conclusions. To overcome the limitation of
the lack of a suitable single assay to track
the efficiency of macroautophagy, we have
employed complementary approaches
to assess the autophagy process, namely
autophagosome abundance in the presence or absence of an inhibitor of lysosomal acidification to assess ‘flux’; relative
abundance of autophagosomes and autolysosomes; relative levels of SQSTM1/p62,
an adaptor protein that gets consumed
during autophagy; and the clearance of
polyglutamine aggregates that are processed through macroautophagy. Our
results indicate that autophagosome clearance may be partially impaired during
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Figure 1. Schematic depicting the proposed outcomes of autophagy in myocardial ischemia-reperfusion injury. Autophagosome formation is induced
by ischemia (hypoxia) via AMPK activation, and further stimulated by reperfusion (reoxygenation) secondary to ROS-induced cellular injury. Previous
work suggests a critical prosurvival role for autophagy in ischemia, by ensuring nutrient supply. Our data demonstrate that both ischemia and reperfusion lead to a decline in LAMP2, which is important for autophagosome-lysosome fusion. Reperfusion-induced ROS also provokes increased BECN1
abundance, which stimulates autophagosome formation, but results in transcriptional inhibition of the autophagy-lysosome machinery. Together,
these provoke marked impairment of autophagosome clearance with resultant autophagosome accumulation, and impaired removal of damaged
cellular constituents. This sets up a vicious cycle of increased ROS generation and mitochondrial permeabilization, culminating in necrotic cell death,
which can be attenuated by cyclosporin A (CsA), an inhibitor of mitochondrial permeability transition pore. ‘?’ indicates undefined mechanisms.

ischemia and is severely impaired during
reperfusion, resulting in accumulation of
autophagosomes, and presumably undigested cargo, which manifests in further
ROS generation, mitochondrial permeabilization and a necrotic mechanism of cell
death (Fig. 1). Importantly, restoring autophagosome processing and reestablishing
adequate flux through macroautophagy
attenuates reoxygenation-induced cardiomyocyte death.
The mechanism for the impairment
in autophagosome processing appears
two-fold. Both ischemia and reperfusion
induce a decline in levels of LAMP2, a
lysosome membrane protein that plays
an important role in autophagosomelysosome fusion, which is driven by ROS
generation with reperfusion. Accordingly,
exogenous expression of either the
LAMP2A or LAMP2B isoform results in
restoration of autophagosome processing
in cardiomyocytes subjected to hypoxiareoxygenation. Additionally, reperfusion
induces a ROS-driven increase in BECN1
abundance. However, shRNA mediated
knockdown of Becn1 transcripts reveals
surprising and dichotomous outcomes with
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reoxygenation, which are dependent on
the degree of knockdown in hypoxia-reoxygenation-treated cardiomyocytes. Partial
Becn1 knockdown results in restoration of
relative predominance of autolysosomes,
suggesting restored autophagosome processing; whereas a more complete knockdown prevents autophagosome formation.
Importantly, partial Becn1 knockdown
also prevents reoxygenation-induced cardiomyocte death, mirroring previous
observations of reduced infarct size in
Becn1 haplo-insufficient mice subjected to
ischemia-reperfusion injury, in vivo; and a
more complete Becn1 knockdown impairs
autophagosome formation and increases
cell death, confirming a critical prosurvival role for autophagy in this setting.
Furthermore, our data suggest that
BECN1 levels transcriptionally regulate
components of the autophagy-lysosome
machinery such that Becn1 knockdown
results in early (within 48 h) transcriptional upregulation of candidate genes as
Map1lc3b, Sqstm1, Rab7 and Lamp1 with
buildup of the respective protein levels,
followed by transcriptional downregulation (except for the Sqstm1 transcript,

Autophagy

which stimulates its own transcription) at
72 h. Interestingly, exogenous expression
of BECN1 to supranormal levels transcriptionally downregulates these genes (except
for Sqstm1); and taken together these
observations point to a critical role for
BECN1 protein abundance in regulating
a transcriptional network that responds
to activation of autophagy to prime the
machinery for its successful and continued ‘adequate’ execution. Unraveling
the details of this network is the focus of
ongoing studies. Based on these data, we
posit that reperfusion-induced ROS stabilizes BECN1 protein resulting in increased
BECN1 abundance, which transcriptionally suppresses the autophagy-lysosome
machinery and paradoxically causes an
impairment in autophagosome processing, with resultant accumulation of autophagosomes (and undegraded cargo) and
cell death. Partial knockdown of BECN1
in this setting relieves the transcriptional
inhibition of the autophagy-lysosome
machinery, enhancing autophagic flux,
whereas adequate BECN1 protein is
available for its obligate role in autophagosome formation. It is conceivable
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stages, i.e., after the formation of autophagosomes, in cardiac ischemia-reperfusion injury, which renders autophagy
‘inadequate’ in preventing cardiomyocyte death. The results also underscore
the need to carefully evaluate the efficiency of the ‘process’ of autophagy with
multiple readouts at various steps, spread
out temporally, to prevent erroneous
conclusions. Importantly, there remains
an acute need for development of better
assays to assess autophagic flux in vivo
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and in vitro, which will facilitate accurate
conclusions regarding its role in health
and disease.
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that other potential outcomes of increased
BECN1 levels, such as interaction with
KIAA0226/rubicon to inhibit autophagosome processing, pro-apoptogenic
caspase-mediated cleavage, modulation of
deubiquitinating enzymes and TP53/p53,
and other hitherto undiscovered mechanisms contribute to its deleterious role in
reperfusion-induced cell death, and will
require further investigation.
In summary, our data demonstrate
that autophagy is impaired at the late

